<unk>  refers to a<unk>  consisting of fludarabine, high-dose cytarabine (AraC) and filgrastim (G-CSF), used as a remission-induction treatment for relapsed or refractory childhood acute myeloid leukemia (AML)
FLAG regimen
FMR regimen
IFL regimen
RCD regimen
R-CVP regimen
TAP regimen
CAF regimen
CEPP regimen